Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Akorn for the product Sodium Chloride (NDC 17478-623). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient, purpose, use, otc - do not use, otc - when using, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Sodium Chloride 5%
Hypertonicity Agent
Do not use
When using this product
Stop use and ask a doctor if
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center immediately.
Instill 1 or 2 drops in the affected eye(s) as needed.
Boric Acid, Hypromellose 2906, Methylparaben 0.23 mg (0.023%), Propylparaben 0.1 mg (0.01%), Propylene Glycol, Sodium Borate, Sodium Hydroxide and/or Hydrochloric Acid to adjust pH (6.0 to 8.0), and Water for Injection.
Principal Display Panel Text for Container Label:
NDC 17478-623-12 Akorn Logo
5%
SODIUM
CHLORIDE
Ophthalmic
Solution, USP
Hypertonicity
Eye Drops
15 mL (0.5 fl. oz.) Sterile
Principal Display Panel Text for Carton Label:
NDC 17478-623-12
5%
SODIUM
CHLORIDE
Ophthalmic
Solution, USP
Hypertonicity Eye Drops
Comparable to Muro-128®*
15 mL (0.5 fl. oz.) Sterile
Akorn Logo
* Please review the disclaimer below.